Application for children and young people
The use of Lorzaar® in children has been investigated, but there is currently still limited experience in the treatment of children and adolescents, so that it is necessary to consult with the treating physician about the extent to which the drug is recommended in the individual case. The use of Lorzaar® is not recommended for children under the age of 6 years, as its efficacy has not been proven and there is insufficient experience with the therapy of small children.
Use during pregnancy/breastfeeding
Lorzaar® must not be taken during pregnancy and lactation!
Roadworthiness and the operation of machines
To date, no studies have been conducted on the influence on roadworthiness or the operation of machines, but an effect of Lorzaar® is unlikely. However, it is possible that Lorzaar®, like other antihypertensive drugs, can cause dizziness or fatigue in patients. A corresponding effect should be clarified by the treating physician.
